What is the NOAEL for C.I. Acid Orange 7?
C.I. Acid Orange 7 has 26 NOAEL studies in the database. The lowest reported value is 0 unitless. Source: NTP ICE endocrine.
Also known as: Acid Orange II, EC No.: 211-199-0, Benzenesulfonic acid, p-(2-hydroxy-1-naphthylazo)-, sodium salt, D&C Orange 4, Acid Leather Orange Extra (+14 more)
CAS 633-96-5
C.I. Acid Orange 7 (CAS 633-96-5) is a chemical substance. Key regulatory status: REACH registered, 12 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, SCCS, ECHA REACH.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Europe; Personal care - hair coloring | Danish Environmental Protection Agency | Danish EPA |
| Europe; Personal care - hair coloring | Danish Environmental Protection Agency | Danish EPA |
| Europe; Personal care - hair coloring | Danish Environmental Protection Agency | Danish EPA |
| Europe; Personal care - hair coloring | Danish Environmental Protection Agency | Danish EPA |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| IFRA Transparency | IFRA | IFRA |
| children; Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care - specialized bath products - bath salts | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care - hair styling and care - shampoo | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| pharmaceutical | FDA | United States Food and Drug Administration (FDA) |
| Personal care | FDA | United States Food and Drug Administration (FDA) |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 2.5 | mg/kg bw/day | - | - | - | Regulatory source |
| 2.5 | mg/kg bw/ day | - | dermal | rabbit | Regulatory source |
| 2.5 | mg/kg bw/d | - | oral | rat | Regulatory source |
| 5 | mg/kg | - | oral | rat | Regulatory source |
| 5 | mg/kg bw/day | - | - | human | Regulatory source |
| =0.176 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB GESTIS DNEL |
| Q1LIY3BO0U | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| =5 | mg/kg bw/day | LOAEL | oral | Rat | ECHA |
| =100 | mg/kg bw/day | LOAEL | oral | Rat | ECHA |
| 0 | unitless | Model Score | - | - | NTP ICE endocrine |
| =0.83 | mg/kg bw/d | NOAEL | oral | rat | SCCS Opinion |
| =2.5 | mg/kg bw/day | NOAEL | - | - | SCCS Opinion |
| =2.5 | mg/kg bw/ day | NOAEL | dermal | rabbit | SCCS Opinion |
| =2.5 | mg/kg bw/d | NOAEL | oral | rat | SCCS Opinion |
| =2.5 | mg/kg | NOAEL | dermal | rabbit | SCCNFP Opinion |
| =5 | mg/kg bw/day | NOAEL | - | human | SCCS Opinion |
| =5 | mg/kg bw/d | NOAEL | oral | rat | SCCS Opinion |
| =5 | mg/kg | NOAEL | oral | rat | SCCNFP Opinion |
| =50 | % | NOAEL | oral | rat | SCCS Opinion |
| =1000 | mg/kg bw/day | NOAEL | oral | Rat | ECHA |
| =0.83 | mg/kg bw/d | dermal absorption | oral | rat | Regulatory source |
| 5 | mg/kg | dermal absorption | oral | rat | Regulatory source |
| 5 | mg/kg bw/d | dermal absorption | oral | rat | Regulatory source |
| 50 | % | dermal absorption | oral | rat | Regulatory source |
| 2.5 | mg/kg | genotoxicity | oral | rat | Regulatory source |
| 2.5 | mg/kg | repeated dose toxicity | dermal | rabbit | Regulatory source |
Showing 26 of 26 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Sodium 4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate | 211-199-0 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
EU Scientific Committee opinions tied to the matched substance.
| Opinion | Date | Conclusion | Max Conc. | Concerns |
|---|---|---|---|---|
| SCCS/1536/14 | 23 September 2014 | safe | 0.5% | moderate sensitiser |
| SCCS/1437/11 | 22 March 2011 | safe | 0.5% | sensitisation potential not excluded |
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS food additive, ADI, and GRAS records where available.
E111 — ADI: DECISION POSTPONED mg/kg bw
View full food safety profile →Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →C.I. Acid Orange 7 has 26 NOAEL studies in the database. The lowest reported value is 0 unitless. Source: NTP ICE endocrine.
C.I. Acid Orange 7 appears on 8 regulatory/inventory lists including Europe; Personal care - hair coloring, inert_ingredient; non_food_use; Pesticides, IFRA Transparency, and 5 more. Source: EPA CPDat.
Yes, C.I. Acid Orange 7 is also indexed as a cosmetic ingredient under the name Orange 4 (CI 15510). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed, EFSA / FDA GRAS, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
C.I. Acid Orange 7 also appears in cosmetics, pharmaceutical, food safety, cannabis databases.